Protection provided by COVID-19 vaccines is compromised due to waning immunity over time. This study aimed to assess the level of antibodies anti-S-RBD of SARS-CoV-2 in a cohort of healthcare workers before and, on average, one and four months after the third dose of the BNT162b2 vaccine. The determination of antibodies was carried out in serum samples using an electrochemiluminescence immunoassay (ECLIA). All 34 participants (10 males, 24 females, 19 participants <50 years old, 15 participants ≥50 years old) showed a significant antibody level increase after the booster dose. Subsequently, a significant decrease in the antibody concentration was observed, with a reduction of about 60% after 150 days from the booster. Six subjects were infe...
The continuous variability of SARS-CoV-2 and the rapid waning of specific antibodies threatens the e...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
The SARS-CoV-2 pandemic led to the development of various vaccines. The BNT162b2 mRNA vaccine was th...
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This...
A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease ...
Antibody levels that confer full protection against SARS-CoV-2 infection after the administration of...
The aim of this study was to investigate the kinetics of neutralizing antibodies (NAbs) and anti-SAR...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
Background: Real-world population studies have shown waning immunity, over time, after receiving the...
SARS-CoV-2 vaccines are highly efficient against severe forms of the disease, hospitalization and de...
Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 v...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
The continuous variability of SARS-CoV-2 and the rapid waning of specific antibodies threatens the e...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
The SARS-CoV-2 pandemic led to the development of various vaccines. The BNT162b2 mRNA vaccine was th...
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This...
A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease ...
Antibody levels that confer full protection against SARS-CoV-2 infection after the administration of...
The aim of this study was to investigate the kinetics of neutralizing antibodies (NAbs) and anti-SAR...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...
Background: Real-world population studies have shown waning immunity, over time, after receiving the...
SARS-CoV-2 vaccines are highly efficient against severe forms of the disease, hospitalization and de...
Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 v...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
The continuous variability of SARS-CoV-2 and the rapid waning of specific antibodies threatens the e...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine eff...